0001203311-23-000105.txt : 20230901
0001203311-23-000105.hdr.sgml : 20230901
20230901165053
ACCESSION NUMBER: 0001203311-23-000105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230831
FILED AS OF DATE: 20230901
DATE AS OF CHANGE: 20230901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LIU JEAN I
CENTRAL INDEX KEY: 0001241357
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 231233193
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2023-08-31
0
0001060736
Seagen Inc.
SGEN
0001241357
LIU JEAN I
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
Chief Legal Officer
0
Common Stock
2023-08-31
4
S
0
1893
206.9659
D
84462
D
The sales reported in this Form 4 were effected pursuant to a written plan adopted on 11/18/2019 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
By: /s/ Jennifer Prosba For: Jean I Liu
2023-09-01